Neurizon Therapeutics has reported positive topline results from an open-label extension (OLE) study of its lead candidate ...

The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...

By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...

Yet another biotech is facing a delay from the FDA as the agency reels from intense staffing cuts. | Yet another biotech is ...

A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting ...

The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.

A new brain-computer interface can decode a person's inner speech, which could help people with paralysis communicate.

SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis: Beijing Monday, August 18, 2025, 18:00 Hrs [I ...

Mark Kirton, who experienced his most productive seasons of his NHL career with the Detroit Red Wings in the early 1980s, ...

It may be time to rethink certain genetic mutations associated with two devastating neurodegenerative disorders—amyotrophic ...

Retired industrial arts teacher Allen Mohr was said to have saved “a lot of kids from the scrap pile,” according to a former ...